The purpose of the Physician Scientist Training Program in Cancer Medicine is to enhance research training opportunities at the University of Wisconsin for physician scientists in the field of cancer medicine. During the past decade, the number of physicians entering academic medicine has declined, partly because of a limited number of institutions committed to the training of physician investigators. As a cancer center with a strong record of training high quality physician investigators and with particularly successful interactions between its laboratory and clinical programs, the University of Wisconsin Comprehensive Cancer Center (UWCCC) is an outstanding site for a formal research training program in cancer medicine. Participants in this program receive at least two years of investigative training in one of the established research programs of the UWCCC, such as genetics, cell signaling, etiology and prevention, cancer control, experimental therapeutics, immunology, virology and radiation and imaging sciences. Trainees work closely with a faculty mentor on a specific project in one of the above areas often with a disease specific focus e.g. breast cancer. Projects are presented to the Physician Scientist Training Grant Committee by the trainee both orally and in written NIH grant format with progress reports presented to this Committee every six months. The trainees are required to enter into the UW Clinical Investigator Preparatory Program which provides a curriculum of didactic courses, seminars, workshops and institutional resources designed for individuals training in clinical research. Applicants are drawn from the UW training programs in Medical Oncology, Radiation Therapy, Pediatric Oncology, Hematology and Internal Medicine. Candidates from other training programs such as Urology, Surgical Oncology, Ophthalmology, Gastroenterology, etc. are considered if the applicant commits himself to focusing on a cancer related project and wishes to pursue a career in cancer medicine. Trainees are chosen based on the depth and quality of the applicant's research proposal. Six traineeships are awarded each year. Over the past 10 years, 17 trainees have completed their training. Fourteen of these trainees have assumed positions in academic medicine on the faculties of university cancer centers. Nine trainees are still in the midst of their fellowships, or residencies, or T32 traineeships.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009614-20
Application #
7644005
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1988-08-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
20
Fiscal Year
2009
Total Cost
$303,291
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Shahzad, Mian M K; Felder, Mildred; Ludwig, Kai et al. (2018) Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src. PLoS One 13:e0189524
Rampurwala, Murtuza; Wisinski, Kari B; Burkard, Mark E et al. (2017) Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Invest New Drugs 35:87-94
Wisinski, Kari B; Tevaarwerk, Amye J; Burkard, Mark E et al. (2016) Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer. Clin Cancer Res 22:2659-67
Hanson, Summer E; Kleinbeck, Kyle R; Cantu, David et al. (2016) Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. J Tissue Eng Regen Med 10:E90-E100
Elsaid, M Y; Capitini, C M; Diamond, C A et al. (2016) Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease. Bone Marrow Transplant 51:1522-1523
Hadac, Jamie N; Miller, Devon D; Grimes, Ian C et al. (2016) Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance. Anticancer Res 36:845-52
Graul-Conroy, Amanda; Hicks, Emily J; Fahl, William E (2016) Equivalent chemotherapy efficacy against leukemia in mice treated with topical vasoconstrictors to prevent cancer therapy side effects. Int J Cancer 138:3011-9
Rampurwala, Murtuza; Wisinski, Kari B; O'Regan, Ruth (2016) Role of the androgen receptor in triple-negative breast cancer. Clin Adv Hematol Oncol 14:186-93
Schneider, David F; Elfenbein, Dawn; Lloyd, Ricardo V et al. (2015) Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer. Ann Surg Oncol 22:158-63
Blute Jr, Michael L; Rushmer, Timothy J; Shi, Fangfang et al. (2015) Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer. J Urol 194:1214-9

Showing the most recent 10 out of 126 publications